Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy
Conditions
Chemotherapy-induced Peripheral Neuropathy
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Institut de Cancérologie de l'Ouest, Angers, France
Contact: Principal Investigator (Florent Bienfait)CHU Bordeaux, Bordeaux, France
Contact: Principal Investigator (Fanny LAFAYE, MD)Centre François Baclesse, Caen, France
Contact: Principal Investigator (Frédérique Bisiaux)CHU Grenoble, Grenoble, France
Contact: Study coordinator (Caroline MAINDET, MD)Contact: Principal Investigator (Caroline MAINDET, MD)Polyclinique Chenieux, Limoges, France
Contact: Principal Investigator (Gaelle Martine Fabre)Centre Léon Bérard, Lyon, France
Contact: Principal Investigator (Olivier RENARD, MD)"L'Hôpital Privé du Confluent ", Nantes, France
Contact: Study coordinator (Thomas CUVIER, MD)Contact: Principal Investigator (Thomas CUVIER, MD)Centre Antoine Lacassagne, Nice, France
Contact: Study coordinator (Anne FOGLIARINI, MD)Contact: Principal Investigator (Anne FOGLIARINI, MD)Institut de Cancérologie de l'Ouest, Saint-Herblain, France
Contact: Principal Investigator (François Xavier Piloquet)Institut de Cancérologie Strasbourg Europe, Strasbourg, France
Contact: Principal Investigator (Anna SCHOHN)Institut Claudius Regaud -IUCT-O, Toulouse, France
Contact: Principal Investigator (Antoine BODEN, MD)
Study leads
François Xavier PILOQUET, MD
Study Director
Institut de Cancérologie de l'Ouest